Intra-Cellular Therapies, Inc. — Form D

Intra-Cellular Therapies, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-11. The offering totals $70.3M, of which $70.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2013-09-11
• Form: D
• Accession: 0001176407-13-000006
• Industry: Biotechnology
• Exemptions: 06
• Total offering: $70.3M
• Amount sold: $70.3M
• Investors: 274
• Date of first sale: 2013-08-29
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-202688

Issuer

• Name: Intra-Cellular Therapies, Inc.
• CIK: 0001567514
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2012
• Address: 3960 BROADWAY, NEW YORK, NY, 10032
• Phone: 212-923-3344

Officers, directors & promoters (7)

More

• CIK 1567514 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search